Related Experiment Video
Updated: Jan 15, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan
Masashi Kasai1,2, Satoshi Nakano3,4, Shota Koide3
1Division of Infectious Disease, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.
Insights
Genomic surveillance in Japan shows current Group B Streptococcus (GBS) vaccines could cover most pediatric invasive infections. Further research into transmission routes is crucial for future prevention strategies.
Area of Science:
- Microbiology
- Genomics
- Epidemiology
Background:
- Group B Streptococcus (GBS) causes severe neonatal and infant infections like sepsis and meningitis.
- Despite antibiotic prophylaxis, GBS remains a significant public health issue.
- This study addresses GBS in Japan, focusing on pediatric invasive infections.
Purpose of the Study:
- Estimate vaccine coverage for pediatric invasive GBS in Japan.
- Characterize the genomic epidemiology of invasive GBS isolates.
- Inform future prevention strategies for GBS infections.
Main Methods:
- Nationwide, multicenter, retrospective genomic surveillance.
- Analysis of 237 GBS isolates from children (≤15 years) in Japan (2004-2023).
- Serotyping, antimicrobial susceptibility testing, whole-genome sequencing, and phylogenetic/SNP analyses were performed.
Main Results:
- Serotype III was most common (48.1%), followed by Ia (27.4%) and Ib (12.2%).
- Estimated vaccine coverage: 98.3% (hexavalent polysaccharide), 94.9% (GBS-NN/NN2 protein).
- High resistance to erythromycin (61.2%) and clindamycin (43.5%); penicillin susceptibility maintained. Dominance of a multidrug-resistant CC17 clone identified. Evidence of nosocomial transmission and regional circulation within ST17 and ST23 lineages.
Conclusions:
- Current maternal GBS vaccine candidates show potential for broad coverage against pediatric invasive infections in Japan.
- Persistent and regionally disseminated lineages necessitate investigation of transmission routes, including environmental reservoirs.
- Genomic data is vital for developing effective future GBS prevention strategies.
Background:
Streptococcus agalactiae (Group B Streptococcus, GBS) is a leading cause of invasive neonatal and infant infections, including sepsis and meningitis. This study aimed to estimate the vaccine coverage and characterize the genomic features of pediatric invasive GBS in Japan.
Methods:
We conducted a nationwide, multicenter, retrospective genomic surveillance study involving 237 GBS isolates from sterile specimens of children aged ≤15 years across 35 hospitals in Japan between 2004 and 2023. Serotyping, antimicrobial susceptibility testing, and whole-genome sequencing were performed.
Results:
The estimated vaccine coverage was 98.3% for the hexavalent polysaccharide vaccine and 94.9% for the GBS-NN/NN2 protein vaccine. Erythromycin and clindamycin resistance were observed in 61.2% and 43.5%, respectively. Among the 75 CC17 isolates, 59 (78.7%) contained only PI-2B and harbored both ermB and tetO, indicating the predominance of a multidrug-resistant clone. Single nucleotide polymorphism-based analysis revealed evidence of nosocomial transmission and persistent regional circulation, particularly within the ST17 and ST23 lineages.
Conclusions:
This study suggests that current maternal GBS vaccine candidates would provide broad coverage for pediatric invasive infections in Japan. The identification of persistent and regionally disseminated lineages highlights the importance of investigating potential, yet, poorly understood, transmission routes, including environmental reservoirs, to inform future prevention strategies.
More Related Videos
13:47Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
Published on: May 19, 2020
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...